Opendata, web and dolomites

SchmaVirusVacDiag

Novel vaccine and diagnostic strategies against Schmallenberg virus

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "SchmaVirusVacDiag" data sheet

The following table provides information about the project.

Coordinator
ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS 

Organization address
address: PARQUE TECNOLOGICO EDIFICIO 801 A
city: DERIO VIZCAYA
postcode: 48160
website: www.cicbiogune.es

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Project website http://www.cicbiogune.es
 Total cost 158˙121 €
 EC max contribution 158˙121 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2014
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2015
 Duration (year-month-day) from 2015-06-15   to  2017-06-14

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS ES (DERIO VIZCAYA) coordinator 158˙121.00

Map

 Project objective

Schmallenberg virus (SV) is a pathogen that has been discovered in European livestock 3 years ago. Since then, it has been found that this virus is associated with disease in sheep, goats and cattle across Europe . In livestock, the symptoms associated with the disease include stillbirths and malformations in newborn animals. The presence of the virus in Spain, France, Germany, Italy, the UK, the Netherlands as well as Russia, has shown that this disease is a fast spreading threat to the European livestock industry, and has the potential to cause significant economic impact across the continent. Furthermore, due to high volumes in international trade of livestock, the potential of this disease to spread beyond Europe poses another potential threat to the industry. Recent work using a related bunyavirus (Rift Valley Fever virus) has found that effective DNA vaccines can be generated . These vaccines have the advantage of being administered easily, having low-manufacturing costs, and providing long-lasting efficacy-making it ideal for large-scale vaccination campaigns. Furthermore, studies on related viruses have shown that monoclonal antibodies can be generated for use in diagnostic testing. Using these concepts, we propose to extend this principle to Schmallenberg virus, in order to: i) develop an easy-to-use diagnostic test for Schmallenberg detection; and ii) develop a DNA vaccination strategy that could be used to limit further future outbreaks.

 Publications

year authors and title journal last update
List of publications.
2017 Hani Y. Boshra, Diego Charro, Gema Lorenzo, Isbene Sánchez, Beatriz Lazaro, Alejandro Brun, Nicola G.A. Abrescia
DNA vaccination regimes against Schmallenberg virus infection in IFNAR −/− mice suggest two targets for immunization
published pages: 107-115, ISSN: 0166-3542, DOI: 10.1016/j.antiviral.2017.02.013
Antiviral Research 141 2019-07-24

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SCHMAVIRUSVACDIAG" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SCHMAVIRUSVACDIAG" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

Migration Ethics (2019)

Migration Ethics

Read More  

EcoSpy (2018)

Leveraging the potential of historical spy satellite photography for ecology and conservation

Read More  

LiquidEff (2019)

LiquidEff: Algebraic Foundations for Liquid Effects

Read More